Medicamen Biotech Limited

Web: medicamen.com NSE: MEDICAMEQ BSE: 531146 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

359 14(4%)

Volume

77k as on 23, Jun

Open

520

High

521

Low

506

346

VWAP

240

52 Week High

448

52 Week Low

212

Viand Research Rating

Quality Score

26/100

Growth Score

25/100

Valuation Score

50/100

Momentum Score

25/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

487

No. of Shares

1.36

P/E

53.7

P/B

2.67

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

4.97

ROCE

Profit Growth

Listing Date

27-Oct-21

Rank/Sector Rank

#2001/#140

Promoter Holding

40.46%

FII Holding

0.07%

DII Holding

0.4%

Price Chart

Price Performance

1 Week6%

1 Month10%

3 Months1%

6 Months17%

1 Year17%

YTD17%

Moving Average

5 Day SMA230

10 Day SMA229

20 Day SMA244

30 Day SMA254

50 Day SMA258

61 Day SMA253

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	233	229	231	236
Resistance 2	231	229	230	233
Resistance 1	230	228	229	233
Pivot Point	228	228	228	229
Support 1	226	228	227	229
Support 2	224	227	226	226
Support 3	223	227	224	226

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,18,698	1745	0%	5%	4%	4%	37	55.5	0.07	11509
2	DIVISLAB	2,43,966	9190	2%	0%	45%	38%	69	55.5	0	2568
3	TORNTPHARM	1,73,208	4554	2%	5%	10%	28%	72	55.5	1.79	2138
4	ZYDUSLIFE	1,11,451	1117	0%	1%	20%	12%	20	55.5	0.31	3560
5	APOLLOHOSP	1,09,276	7600	2%	9%	4%	1%	58	55.5	0.9	2003
6	LAURUSLABS	1,08,738	2012	1%	8%	83%	124%	0	55.5	0.48	890
7	CIPLA	1,06,154	1314	2%	2%	8%	19%	22	55.5	0.02	3862
8	DRREDDY	1,03,873	1244	3%	8%	1%	4%	20	55.5	0.2	4158
9	MANKIND	94,401	2286	4%	1%	8%	7%	49	55.5	0.39	1938
10	AUROPHARMA	90,841	1579	2%	1%	20%	52%	0	55.5	0.19	2415
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Apr 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 40.46%	(0.01) 40.46%	(0.01) 40.46%	(0.01) 40.46%	(0.01) 40.46%	(-2.71) 40.46%	(0.21) 43.16%	(0.01) 42.99%	(0.01) 42.99%	(-0.21) 42.99%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(0.01) 43.21%	(-0.41) 43.21%	(0.01) 43.60%	(0.01) 43.60%	(-1.21) 43.60%	(0.01) 44.83%
FIIs	(0.01) 0.07%	(0.11) 0.10%	(0.01) 0.02%	(0.11) 0.05%	(-0.21) 0.00%	(0.11) 0.22%	(0.11) 0.12%	(0.01) 0.06%	(0.01) 0.06%	(-0.11) 0.06%	(-0.11) 0.12%	(0.01) 0.22%	(0.11) 0.22%	(0.01) 0.16%	(0.01) 0.19%	(-1.71) 0.17%	(1.51) 1.83%	(-0.11) 0.35%	(0.11) 0.40%	(0.01) 0.35%	(0.01) 0.35%
DIIs	(0.41) 0.40%	(-0.41) 0.00%	(-0.21) 0.44%	(-0.11) 0.59%	(0.01) 0.64%	(0.01) 0.65%	(-0.21) 0.69%	(-0.31) 0.87%	(0.01) 1.17%	(0.21) 1.17%	(0.31) 0.99%	(0.51) 0.67%	(0.01) 0.20%	(0.01) 0.20%	(0.01) 0.20%	(0.11) 0.20%	(0.11) 0.13%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Government	0.05%	0.05%	0.05%	0.05%	0.05%	0.05%	0.06%	0.06%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	59.01%	59.39%	59.02%	58.84%	58.83%	58.62%	55.99%	56.04%	55.79%	55.78%	55.69%	55.90%	56.38%	56.44%	56.40%	56.42%	54.84%	56.06%	56.01%	56.06%	54.82%
No. of Shareholders	11,047	10,806	10,967	11,177	10,808	10,592	10,435	10,576	10,792	10,652	10,639	10,252	9,419	8,272	8,233	8,273	8,332	9,107	9,300	9,140	5,595

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	43.85	54.68	43.49	42.23	38.45	26	41.14	42.84	41.48	45.01	44.2	42.67	40.5	38.67	35.58	33.53	33.09	22.75	32.64	32.52	27.53
Sales Growth % (YoY)	14%	110.3%	5.7%	-1.4%	-7.3%	-42.2%	-6.9%	0.4%	2.4%	21.2%	29.5%	27.3%	22.4%	70%	9%	3.1%	20.2%	7.1%	-0.8%	5.7%	-0.9%
Sales Growth % (QoQ)	-19.8%	25.7%	3%	9.8%	47.9%	-36.8%	-4%	3.3%	-7.8%	1.8%	3.6%	5.4%	4.7%	8.7%	6.1%	1.3%	45.5%	-30.3%	0.4%	18.1%	-
Expenses	39.07	50.56	38.41	37.18	34.42	27.1	34.9	36.29	36.62	38.18	38.61	36.51	33.09	32.18	29.71	27.67	27.43	17.79	26.34	26.3	21.49
Operating Profit	4.78	4.12	5.08	5.05	4.03	-1.1	6.24	6.55	4.86	6.83	5.59	6.16	7.41	6.49	5.87	5.86	5.66	4.96	6.3	6.22	6.04
OPM %	10.9	7.53	11.68	11.96	10.48	-4.23	15.17	15.29	11.72	15.17	12.65	14.44	18.3	16.78	16.5	17.48	17.1	21.8	19.3	19.13	21.94
Other Income	0.86	1.73	0.53	0.37	0.47	5.22	0.14	0.29	0.58	0.54	0.83	0.55	0.38	0.35	0.63	0.52	0.96	0.34	0.83	0.48	0.08
Interest	0.64	0.6	0.78	0.84	0.56	0.62	0.73	1.01	0.68	1.87	0.65	0.91	0.96	0.86	0.68	0.62	0.77	0.56	0.49	0.3	0.04
Depreciation	1.74	1.73	1.75	1.81	1.77	0.47	2.17	2.57	1.74	1.77	1.76	1.8	1.68	1.62	1.6	1.62	1.53	1.52	1.57	1.35	1.33
Profit before tax	3.26	3.52	3.08	2.77	2.17	3.03	3.48	3.26	3.02	3.73	4.01	4	5.15	4.36	4.22	4.14	4.32	3.22	5.07	5.05	4.75
Tax %	22.39	15.62	15.58	20.22	24.42	20.79	27.59	30.06	25.17	16.62	31.17	24.75	14.37	13.53	10.66	13.04	17.13	14.6	25.64	16.44	12.42
Net Profit	2.53	2.97	2.59	2.21	1.64	2.41	2.52	2.27	2.26	3.1	2.77	3.01	4.42	3.77	3.77	3.6	3.59	2.75	3.78	4.22	4.15
Net Profit Growth % (QoQ)	-14.8%	14.7%	17.2%	34.8%	-32%	-4.4%	11%	0.4%	-27.1%	11.9%	-8%	-31.9%	17.2%	-	4.7%	0.3%	30.5%	-27.2%	-10.4%	1.7%	-
Net Profit Growth % (YoY)	54.3%	23.2%	2.8%	-2.6%	-27.4%	-22.3%	-9%	-24.6%	-48.9%	-17.8%	-26.5%	-16.4%	23.1%	37.1%	-0.3%	-14.7%	-13.5%	-	-	-	-
TTM Net Profit	10.3	9.41	8.85	8.78	8.84	9.46	10.15	10.4	11.14	13.3	13.97	14.97	15.56	14.73	13.71	13.72	14.34	14.9	12.15	8.37	0
EPS in Rs	1.87	2.19	1.91	1.63	1.21	1.9	1.98	1.79	1.78	2.44	2.19	2.38	3.49	3.07	2.97	2.85	2.94	2.25	3.09	3.45	3.4

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	179	151	172	138	115	110	117	123	112	82	67	78
Sales Growth %	18.1%	-12.1%	25%	19.4%	4.8%	-6.1%	-4.3%	10%	35.2%	22.6%	-13.5%	6.2%
Expenses	159	134	145	113	91	90	99	105	95	71	62	73
Operating Profit	19	17	27	25	24	20	18	17	17	12	6	5
OPM %	11	11	16	18	21	18	15	14	15	14	8	6
Other Income	3	6	2	2	2	1	2	4	2	0	1	1
Interest	4	4	6	3	2	2	1	1	3	4	4	4
Depreciation	7	7	7	6	6	3	2	2	2	2	2	2
Profit before tax	12	13	17	17	18	17	17	18	14	6	1	0
Tax %	19	26	21	13	18	25	26	31	27	19	32	-267
Net Profit	9	9	13	15	15	12	12	12	10	5	0	0
Net Profit Growth %	-	-30.8%	-13.3%	-	25%	-	-	20%	100%	-	-	-
EPS in Rs	6.94	7.43	10.46	11.86	12.2	10.22	10.04	10.28	8.89	4.91	0.48	0.46
Dividend Payout %	14	13	10	8	8	10	5	10	12	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Cash from Operating Activity	-29	-3	0	-4	5	13	12	4	-5	4	6	-3
Cash from Investing Activity	-3	-2	-9	-8	-8	-18	-39	-15	-8	-2	-1	0
Cash from Financing Activity	60	-7	3	28	4	6	21	-4	33	-1	-5	3
Net Cash Flow	28	-11	-6	17	1	1	-6	-14	20	0	0	0

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	14	14	13	13	13	13	12	12	12	12	12	11	10	10
Reserves	266	262	205	203	196	181	136	122	110	75	63	16	8	8
Borrowings	38	39	27	20	30	26	26	19	11	12	14	18	19	21
Other Liabilities	44	53	48	52	55	57	52	39	43	38	28	29	23	31
Total Liabilities	362	367	293	289	294	277	226	192	176	137	118	73	60	69
Fixed Assets	84	86	86	89	91	92	92	90	34	24	25	19	19	20
CWIP	0	0	0	0	0	0	0	0	40	15	0	0	0	0
Investments	8	8	8	0	8	4	2	2	2	0	0	0	0	0
Other Assets	270	273	199	200	195	180	131	101	100	97	92	54	41	49
Total Assets	362	367	293	289	294	277	226	192	176	137	118	73	60	69

Delivery

Delivery Data: MEDICAMEQ

#	Date	215 69% 364	Value (Cr)	Q/T 35	Del 59	Del 2
1	17-Sep	346	5	27	48	2
2	16-Sep	346	8	27	36	3
3	15-Sep	318	5	34	52	3
4	11-Sep	323	6	36	50	3
5	10-Sep	308	6	34	40	3
6	9-Sep	313	11	48	42	5
7	8-Sep	286	2	34	56	1
8	7-Sep	279	4	44	57	2
9	4-Sep	270	3	44	48	2
10	3-Sep	259	1	37	56	0
11	2-Sep	265	2	45	65	1
12	1-Sep	267	4	27	46	2
13	31-Aug	261	3	34	54	2
14	28-Aug	249	2	36	65	1
15	27-Aug	231	1	39	66	0
16	26-Aug	241	0	35	55	0
17	25-Aug	238	0	29	67	0
18	24-Aug	234	1	23	64	0
19	21-Aug	245	1	24	70	1
20	20-Aug	244	1	36	76	1
21	19-Aug	229	0	23	73	0
22	18-Aug	226	1	24	67	0
23	17-Aug	220	1	32	76	1
24	14-Aug	240	0	22	82	0
25	13-Aug	241	0	26	77	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
17-Sep	487c	62c	14.55
10-Sep	425c	61c	16.83
07-Sep	364c	0	0

Stock Checklist

Price is above from 52 week high low average: 62%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView